← Back to Analyst Consensus 
NSPR Buy
InspireMD, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 5, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| May 12, 2025 | Piper Sandler | maintain | Overweight → Overweight | $4 | 54% |
| Dec 11, 2024 | Lake Street | initiate | — → Buy | $5 | 47% |
| Nov 2, 2023 | Piper Sandler | maintain | Overweight → Overweight | $4.5 | 54% |
| Jun 12, 2023 | Piper Sandler | initiate | — → Overweight | $3 | 54% |
| May 17, 2023 | National Alliance Securities | maintain | — → Buy | $4.75 | — |
| Mar 31, 2023 | Alliance Global Partners | maintain | — → Buy | $5.15 | 41% |
Price Target Trend
Apr 3, 2026 Latest: $3.33 Oct 24, 2026
EPS Estimates
0q $-0.15
Lo: $-0.16 Hi: $-0.15
3 analysts ▲3
+1q $-0.13
Lo: $-0.14 Hi: $-0.12
3 analysts ▲3
+1y $-0.48
Lo: $-0.52 Hi: $-0.45
3 analysts ▲3
0y $-0.45
Lo: $-0.63 Hi: $-0.13
3 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days